The UKB envirome of depression: from interactions to synergistic effects.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 07 2019
Historique:
received: 09 12 2018
accepted: 19 06 2019
entrez: 7 7 2019
pubmed: 7 7 2019
medline: 21 10 2020
Statut: epublish

Résumé

Major depressive disorder is a result of the complex interplay between a large number of environmental and genetic factors but the comprehensive analysis of contributing environmental factors is still an open challenge. The primary aim of this work was to create a Bayesian dependency map of environmental factors of depression, including life stress, social and lifestyle factors, using the UK Biobank data to determine direct dependencies and to characterize mediating or interacting effects of other mental health, metabolic or pain conditions. As a complementary approach, we also investigated the non-linear, synergistic multi-factorial risk of the UKB envirome on depression using deep neural network architectures. Our results showed that a surprisingly small number of core factors mediate the effects of the envirome on lifetime depression: neuroticism, current depressive symptoms, parental depression, body fat, while life stress and household income have weak direct effects. Current depressive symptom showed strong or moderate direct relationships with life stress, pain conditions, falls, age, insomnia, weight change, satisfaction, confiding in someone, exercise, sports and Townsend index. In conclusion, the majority of envirome exerts their effects in a dynamic network via transitive, interactive and synergistic relationships explaining why environmental effects may be obscured in studies which consider them individually.

Identifiants

pubmed: 31278308
doi: 10.1038/s41598-019-46001-5
pii: 10.1038/s41598-019-46001-5
pmc: PMC6611783
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9723

Références

Biol Psychiatry. 2011 Apr 15;69(8):762-71
pubmed: 21215389
Transl Psychiatry. 2016 May 03;6:e798
pubmed: 27138797
Psychol Med. 2015;45(12):2583-94
pubmed: 25994116
PLoS Comput Biol. 2017 Jun 23;13(6):e1005487
pubmed: 28644851
Dev Psychol. 2014 Nov;50(11):2549-57
pubmed: 25347305
Sci Rep. 2018 Mar 2;8(1):3946
pubmed: 29500446
Nat Commun. 2018 Apr 16;9(1):1470
pubmed: 29662059
Br J Psychiatry. 2017 Aug;211(2):70-76
pubmed: 28642257
Transl Psychiatry. 2016 Nov 1;6(11):e936
pubmed: 27801895
Front Psychiatry. 2014 May 15;5:48
pubmed: 24860514
Pharmacol Ther. 2019 Feb;194:22-43
pubmed: 30189291
Neural Comput. 2006 Jul;18(7):1527-54
pubmed: 16764513
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Obes Res. 1996 May;4(3):245-52
pubmed: 8732958
Can J Psychiatry. 2001 Jun;46(5):422-5
pubmed: 11441781
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Arch Gen Psychiatry. 2006 Oct;63(10):1113-20
pubmed: 17015813
Am J Psychiatry. 2000 Oct;157(10):1552-62
pubmed: 11007705
Int J Obes (Lond). 2008 Jun;32(6):881-91
pubmed: 18414420
PLoS One. 2013 Nov 25;8(11):e75362
pubmed: 24282498
Neuropsychopharmacology. 2014 Nov;39(12):2857-66
pubmed: 24917196
Nat Methods. 2010 Apr;7(4):247-8
pubmed: 20354511
Acta Psychiatr Scand. 1997 Apr;95(4):336-42
pubmed: 9150829
Am J Psychiatry. 2006 Jan;163(1):115-24
pubmed: 16390898
Nat Rev Genet. 2012 Jul 10;13(8):537-51
pubmed: 22777127
Brain Behav Immun. 2016 Aug;56:96-104
pubmed: 26891860
J Affect Disord. 2012 Dec 20;143(1-3):47-55
pubmed: 22858211
Mol Psychiatry. 2015 Jun;20(6):735-43
pubmed: 25917368
Biostatistics. 2008 Jul;9(3):432-41
pubmed: 18079126
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Science. 2003 Jul 18;301(5631):386-9
pubmed: 12869766
Br J Addict. 1991 Oct;86(10):1283-98
pubmed: 1836410
Clin Child Fam Psychol Rev. 2014 Dec;17(4):357-67
pubmed: 24817170
Psychol Med. 2002 May;32(4):719-28
pubmed: 12102386
Psychol Med. 2016 Oct;46(14):2883-2906
pubmed: 27523506
J Dev Behav Pediatr. 2009 Oct;30(5):376-84
pubmed: 19692930
PLoS One. 2015 Mar 06;10(3):e0116316
pubmed: 25747798
Psychol Med. 1999 Sep;29(5):1101-9
pubmed: 10576302
Depress Anxiety. 2009;26(4):325-34
pubmed: 19263467
PLoS One. 2013 Nov 28;8(11):e80507
pubmed: 24312229
Mol Psychiatry. 2018 Jan;23(1):133-142
pubmed: 28373689
Br J Psychol. 2004 Nov;95(Pt 4):509-21
pubmed: 15527535
Am J Psychiatry. 2006 May;163(5):857-64
pubmed: 16648327
Clin Psychol Rev. 2007 Dec;27(8):959-85
pubmed: 17448579
Mol Psychiatry. 2019 Jan;24(1):18-33
pubmed: 29453413
Curr Opin Psychiatry. 2006 Jan;19(1):34-9
pubmed: 16612176
J Affect Disord. 2011 Dec;135(1-3):100-5
pubmed: 21824661
J Affect Disord. 2014 Mar;156:8-23
pubmed: 24308895
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
J Adolesc Health. 2014 Jan;54(1):88-93
pubmed: 24060574
Front Psychiatry. 2014 Dec 11;5:179
pubmed: 25566100
Am J Psychiatry. 2002 Jul;159(7):1133-45
pubmed: 12091191
Nat Rev Genet. 2014 May;15(5):335-46
pubmed: 24739678
Neuropsychopharmacology. 2009 Jul;34(8):2019-27
pubmed: 19242408
J Child Psychol Psychiatry. 2013 Oct;54(10):1120-34
pubmed: 23808649
Soc Sci Med. 2009 Jul;69(2):229-37
pubmed: 19501441
Ment Health Fam Med. 2008 Mar;5(1):15-21
pubmed: 22477842
Aust N Z J Psychiatry. 2010 Aug;44(8):681-96
pubmed: 20636189
Psychoneuroendocrinology. 2015 Feb;52:251-60
pubmed: 25544737
BMC Public Health. 2009 Jan 13;9:14
pubmed: 19144098
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1666-73
pubmed: 24706871
Am J Epidemiol. 2003 Dec 15;158(12):1139-47
pubmed: 14652298
Obes Res. 1998 Sep;6(5):338-45
pubmed: 9738549

Auteurs

Gabor Hullam (G)

Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, H-1117, Hungary.
MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, H-1089, Hungary.

Peter Antal (P)

Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, H-1117, Hungary.

Peter Petschner (P)

MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, H-1089, Hungary.
Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, H-1089, Hungary.

Xenia Gonda (X)

MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, H-1089, Hungary.
NAP2-SE New Antidepressant Target Research Group Semmelweis University, Budapest, H-1089, Hungary.
Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.

Gyorgy Bagdy (G)

MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, H-1089, Hungary.
Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, H-1089, Hungary.
NAP2-SE New Antidepressant Target Research Group Semmelweis University, Budapest, H-1089, Hungary.

Bill Deakin (B)

Neuroscience and Psychiatry Unit, Division of Neuroscience and Experimental Psychology, University of Manchester and Manchester Academic Health Sciences Centre, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Prestwich, Manchester, UK.

Gabriella Juhasz (G)

Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, H-1089, Hungary. juhasz.gabriella@pharma.semmelweis-univ.hu.
Neuroscience and Psychiatry Unit, Division of Neuroscience and Experimental Psychology, University of Manchester and Manchester Academic Health Sciences Centre, Manchester, M13 9PL, UK. juhasz.gabriella@pharma.semmelweis-univ.hu.
SE-NAP2 Genetic Brain Imaging Migraine Research Group, Semmelweis University, Budapest, H-1089, Hungary. juhasz.gabriella@pharma.semmelweis-univ.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH